The Patent Finder

Pelican Technology Holdings, Inc.

17 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
8
Ending by 2030
Jan 2028
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Apr 27, 2027
    The maintenance fee for Process for purifying recombinant Plasmodium falciparum circumsporozoite protein (US 9,169,304) comes due Apr 27, 2027. Unpaid by Oct 27, 2027, it lapses early.
  • 1 fee due Jul 26, 2027
    The maintenance fee for Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids therein (US 9,243,253) comes due Jul 26, 2027. Unpaid by Jan 26, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,618,799Bacterial leader sequences for increased expression
In force
 · USPTO record
In forceUSPTO record
US 7,833,752Bacterial leader sequences for increased expression
In force
 · USPTO record
In forceUSPTO record
US 7,985,564Expression systems with sec-system secretion
In force
 · USPTO record
In forceUSPTO record
US 10,689,640Method for Rapidly Screening Microbial Hosts to Identify Certain Strains with Improved Yield And/Or Quality in the Expression of Heterologous Proteins
In force
 · Medium confidence
In forceMedium confidence
US 9,394,571Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
In force
 · USPTO record
In forceUSPTO record
US 9,580,719Method for Rapidly Screening Microbial Hosts to Identify Certain Strains with Improved Yield and/or Quality in the Expression of Heterologous Proteins
In force
 · Low confidence
In forceLow confidence
US 8,906,636High level expression of recombinant toxin proteins
In force
 · USPTO record
In forceUSPTO record
US 9,708,616Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids therein
In force
 · USPTO record
In forceUSPTO record
US 8,455,218Methods for G-CSF production in a Pseudomonas host cell
In force
 · USPTO record
In forceUSPTO record
US 8,530,171High level expression of recombinant toxin proteins
In force
 · USPTO record
In forceUSPTO record
10 of 17 patents shown.
Pro members see all 17.
Pro members: see all 17 patents
Also on record, not counted in the 17: 4 lapsed for an unpaid fee · 7 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited